EU health policy

Public health benefits of homeopathic and anthroposophic medicinal products

• These long-established therapies and their medicinal products have a role to play in the face of major health challenges in the EU.
• They offer valuable treatment options in support of EU health policy goals on multimorbidity, polypharmacy, chronic diseases and an ageing population.
• They can contribute to safe and effective strategies to reduce the use of antibiotics.
• These cost-effective medicines can contribute to the financial sustainability of health systems.

Freedom of choice for EU citizens

Some 100 million EU citizens make use of homeopathic and anthroposophic medicinal products. It is an important EU principle that patients should have access to the medicinal products of their choice, and this should include traditional medicinal products as much as it does innovative medicines.

Contribution to current EU priorities

Studies and data from the area of health insurance demonstrate the important economic benefit of integrating homeopathic and anthroposophic treatments in regular and standard healthcare. 

These treatments and their related products have an important contribution to make to major EU health challenges.

Research in these fields confirms significant added value to society. These include:

• Comparative effectiveness
• Fewer side effects
• Comparative cost-effectiveness
• Satisfied patients.

A valuable contribution

• Antimicrobial resistance
• Healthy ageing
• Non-communicable disease